Cell Point (India) Limited

🔴 Bear CaseWhat could go wrong?

1. Margins are being competed away
   EBITDA margin has fallen from 6.4% to 3.0%. If the trend continues, profit falls even on flat sales — and margin decline rarely reverses quickly.
2. The debt load needs earnings to hold up
   Debt is 7.3x EBITDA. At that level a downturn in earnings turns a manageable balance sheet into a refinancing problem, and lenders get paid before shareholders.
3. Sales are being booked faster than collected
   Receivables are up 654% against revenue up 25%. If customers keep taking longer to pay, reported profit will not turn into cash — and write-offs follow if some never do.
4. Growth barely outpaces inflation
   Revenue compounding at 7.8% a year is close to the rate prices rise, so the business is gaining little ground in real terms. That leaves the share price dependent on a re-rating rather than on earnings growth.
5. Returns on shareholder capital are falling
   ROE has dropped from 33.5% to 0.1%. Each rupee of equity earns less than it did, so profit growth increasingly depends on raising more capital rather than on the existing base working harder.